Publications
35 results found
Talukder YS, Kafatos G, De Moira AP, et al., 2007, The seroepidemiology of varicella zoster virus among pregnant Bangladeshi and white British women in the London Borough of Tower Hamlets, UK, EPIDEMIOLOGY AND INFECTION, Vol: 135, Pages: 1344-1353, ISSN: 0950-2688
- Author Web Link
- Cite
- Citations: 31
de Moira AP, Fulford AJC, Kabatereine NB, et al., 2007, Microgeographical and tribal variations in water contact and <i>Schistosoma mansoni</i> exposure within a Ugandan fishing community, TROPICAL MEDICINE & INTERNATIONAL HEALTH, Vol: 12, Pages: 724-735, ISSN: 1360-2276
- Author Web Link
- Cite
- Citations: 34
de Moira AP, Edmunds WJ, Breuer J, 2006, The cost-effectiveness of antenatal varicella screening with post-partum vaccination of susceptibles, VACCINE, Vol: 24, Pages: 1298-1307, ISSN: 0264-410X
- Author Web Link
- Cite
- Citations: 16
Pinot de Moira A, Nardone A, On Behalf Of The Esen Group, 2005, Varicella zoster virus vaccination policies and surveillance strategies in Europe., Euro Surveill, Vol: 10, Pages: 3-4
The incorporation of varicella zoster virus (ZVV) vaccination in childhood immunisation schedules is becoming an increasingly common option in Europe. The current study forms part of the European Sero-Epidemiology Network 2 (ESEN2) organisational analysis for VZV and describes current passive immunisation policies, as well as current and proposed active immunisation strategies, and existing surveillance systems for diseases caused by the varicella zoster virus in ESEN countries.
Pinot de Moira A, Nardone A, ESEN2 group, 2005, Varicella zoster virus vaccination policies and surveillance strategies in Europe., Euro Surveill, Vol: 10, Pages: 43-45
The incorporation of varicella zoster virus (ZVV) vaccination in childhood immunisation schedules is becoming an increasingly common option in Europe. The current study forms part of the European Sero-Epidemiology Network 2 (ESEN2) organisational analysis for VZV and describes current passive immunisation policies, as well as current and proposed active immunisation strategies, and existing surveillance systems for diseases caused by the varicella zoster virus in ESEN countries. A questionnaire was compiled and distributed to 23 participating countries. A VZV vaccine is currently licensed in 14 of the 20 participating ESEN countries. Germany is the only country to have incorporated VZV vaccination into its routine childhood immunisation programme. Three further countries currently recommend vaccination of children against VZV and five countries are also considering introducing routine immunisation against VZV for children. However, of the eight countries with or considering introducing childhood VZV immunisation, only six have case-based mandatory notification of varicella, and only two countries have primary care surveillance data available for herpes zoster.
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.